| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |